| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 46.85% | 59.51% | 25.58% | 53.77% | 27.26% | -132.37% | -75.75% |
| Operating Margin | -88.53% | -90.68% | -220.96% | -263.01% | -308.04% | -349.43% | -370.87% |
| EBITDA Margin | -81.67% | -79.84% | -207.75% | -254.92% | -304.70% | -346.59% | -368.12% |
| Net Margin | -78.95% | -88.34% | -202.88% | -229.90% | -51.80% | -351.87% | -361.44% |
| Current Ratio | 3.83 | 3.99 | 5.22 | 6.96 | 10.27 | 0.11 | — |
| Quick Ratio | 2.88 | 2.53 | 3.57 | 5.79 | 9.55 | -9.09 | — |
| Debt / Equity | — | — | — | — | — | — | — |
| ROE | -39.32% | -42.94% | -60.76% | -51.86% | -7.24% | -3254.89% | — |
| ROA | -25.99% | -28.31% | -43.94% | -40.41% | -5.67% | -39.25% | — |
| Asset Turnover | 0.33 | 0.32 | 0.22 | 0.18 | 0.11 | 0.11 | — |
| Book Value / Share | 0.79 | 0.80 | 1.07 | 1.63 | 2.58 | 0.83 | — |
Butterfly Network Inc. is a digital health company specializing in portable, semiconductor-based ultrasound technology. It develops and commercializes whole-body handheld ultrasound probes, including the Butterfly iQ+, iQ3, iQ+ Bladder for specialized bladder scanning, and iQ+ Vet for veterinary applications, all powered by patented Ultrasound-on-Chip™ technology. These single-probe devices enable real-time imaging across multiple specialties and integrate with cloud-based software, advanced AI tools like Compass AI™ for workflow management, ambient documentation, and quality assurance, as well as enterprise platforms for hospital networks. The solutions support point-of-care ultrasound (POCUS) in diverse settings, from individual practices and health systems to medical education and global health initiatives in limited-resource areas. Butterfly Network Inc. serves clinicians, healthcare providers, veterinarians, and organizations worldwide, enhancing clinical decision-making, improving efficiencies, and promoting accessible medical imaging. Founded in 2011 and headquartered in Burlington, Massachusetts, the company drives innovation in democratizing ultrasound for better patient outcomes.